SURMODICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.56 USD | +1.70% |
|
+6.24% | -7.68% |
| May. 02 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
| May. 01 | Top Midday Gainers | MT |
Presentation Operator MessageOperator (Operator)Good day, and welcome to Surmodics 2021 Annual...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Calendar
2024-07-30
- Q3 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
33.56
USD
Average target price
58.25
USD
Spread / Average Target
+73.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.68% | 479M | |
| -4.98% | 182B | |
| +2.84% | 112B | |
| -2.68% | 68.58B | |
| +4.53% | 51.58B | |
| +8.00% | 44.24B | |
| +9.45% | 43.65B | |
| +25.30% | 32.46B | |
| +20.94% | 25.99B | |
| -0.17% | 25.61B |
- Stock Market
- Equities
- SRDX Stock
- News Surmodics, Inc.
- Transcript : Surmodics, Inc. - Shareholder/Analyst Call